Savannah Kohler

Recommended Articles

• What Are the Warning Signs of Hypertensive Crisis?

  High blood pressure or hypertension is a chronic condition that may lead to other complications, including organ damage, gradually over a period of time. The blood pressure may become very high and severe all of a sudden resulting in a condition referred to as hypertensive crisis. Hypertensive...

• What is Blepharitis?

  What is Blepharitis?Blepharitis is the inflammation of the eyelids, usually affecting both of the eyelids where eyelashes grow.The inflammation of the eyelids is often a chronic medical condition, which is very hard to treat. Blepharitis is a condition that does not affect vision. It is also not...

• What Are Hallucinations?

  In psychiatry, hallucinations are defined as a perception experienced in the absence of an external stimulus to the corresponding sense organ. In simple terms, hallucinations are when people see, hear, feel, smell, or taste things that really don’t exist outside of their minds. For a...

• Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux

  Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...

• Diversifying Healthcare: Male and Minorities as Nurses

  In November 1854, Florence Nightingale, with a slew of volunteer nurses that she had trained, arrived to aid the wounded during the Crimean War. This incident catapulted women into the nursing industry and became a staple for many years to come. ...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...